FPN General Partner LLC
- SEC CIK
- 0001860059
No open-market purchases or sales filed in the past year.
Current role at each company
- GENB Generate Biomedicines, Inc.10% Owneras of Mar 2, 2026
- OMGA Omega Therapeutics, Inc.10% Owneras of Aug 5, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists FPN General Partner LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GENB Generate Biomedicines, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 (view filing)5:52 PM ET | Mar 2 | Same day | Afeyan Noubar and 7 othersDirector, 10% Owner | PPurchase | +4.69M | $16.00 | +$75.0M | New position1.56M after | 3 lotsDuplicate filing |
OMGA Omega Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 (view filing)5:41 PM ET | Aug 3 | 2 days | Afeyan Noubar and 9 othersDirector, 10% Owner | PPurchase | +1.18M | $17.00 | +$20.0M | +266.7%1.62M after | 3 lots |